Table 3. Detected genes associated with resistance to different classes of antibiotics and phenotypic susceptibility profiles to most of these classes of antibiotics.
Species ID | TOB | CIP | TMP | SXT | Aminoglycoside† | Quinolone | TMP | SUL | TET | MAC |
---|---|---|---|---|---|---|---|---|---|---|
K. pneumoniae | ||||||||||
13 | 8 | 0.5 | ≥16 | ≥320 | aac(3)-IIda,strA,strB | oqxAa,oqxBa, QnrS1 | dfrA1 | sul1, sul2 | tet(A), tet(D) | |
5 | 8 | ≥4 | ≥16 | ≥320 | aadA16a,aac(6')Ib-cr | oqxAa,oqxBa, QnrB49a,QnrS1 | dfrA27 | sul1 | tet(A)a | mph(A) |
19 | 8 | 1 | ≤0.5 | ≤20 | aac(3)-IIda,strA,strB | oqxAa,oqxBa, QnrS1 | sul2 | tet(D) | ||
16 | 8 | 0.5 | ≥16 | ≤20 | aac(3)-IIda | oqxAa,oqxBa, QnrS1 | dfrA1 | sul1 | tet(A) | |
6 | 8 | ≥4 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, strAa,strBa, aac(6')Ib-cr |
oqxAa,oqxBa, QnrB6 | dfrA27 | sul1, sul2 | tet(D) | |
20,21 | 8 | ≥4 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, aph(3')-Iaa,strA,strB, aac(6')Ib-cr | oqxAa,oqxBa, QnrB49a,QnrS1 | dfrA27 | sul2 | tet(A)a | mph(A) |
18 | 8 | 0.5 | 8 | 40 | aac(3)-IIda,aadA16a, strAa,strBa,aacA4a, aac(6')Ib-cra | oqxAa,oqxBa, QnrB6 | dfrA27 | sul1, sul2 | tet(D) | |
14 | 2 | ≥4 | ≥16 | ≥320 | aadA16a,aac(6')Ib-cr | oqxA,oqxB | dfrA27 | sul1 | tet(D) | |
15 | 4 | ≥4 | ≥16 | ≥320 | aadA16a,aac(6')Ib-cr | oqxA,oqxB | dfrA27 | sul1 | tet(D) | |
17 | 8 | 0.5 | ≥16 | ≥320 | aac(3)-IIda, strAa,strBa | oqxAa,oqxBa, QnrS1 | dfrA14a | sul2 | tet(A)a | mph(A) |
7,8,9 | 8 | ≥4 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, aac(6')Ib-cr | oqxAa,oqxBa | dfrA27 | sul1, sul2 | tet(A)a, tet(D) | |
11 | 8 | ≤0.25 | ≤0.5 | ≤20 | aac(3)-IIda, strAa,strBa | oqxAa,oqxBa, QnrB6 | sul1, sul2 | tet(D) | ||
12 | ≤1 | 1 | ≥16 | ≥320 | strA,strB | oqxAa,oqxBa, QnrS1 | dfrA14a | sul2 | ||
10 | 8 | ≥4 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, aac(6')Ib-cr | oqxAa,oqxBa, QnrB49a | dfrA27 | sul1, sul2 | tet(A)a, tet(D) | |
4 | 8 | 2 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, aph(3')-Iaa,strA,strB, aac(6')Ib-cr | oqxAa,oqxBa, QnrB49a,QnrS1 | dfrA27 | sul1, sul2 | tet(A)a | mph(A) |
1,2,3 | 8 | 2 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, aph(3')-Iaa,strA,strB, aac(6')Ib-cr | oqxAa,oqxBa, QnrB49a,QnrS1 | dfrA27 | sul1, sul2 | tet(A)a | mph(A) |
K. oxytoca | ||||||||||
29 | ≤1 | ≤0.25 | ≤0.5 | ≤20 | aph(3')-Iaa | |||||
33 | 8 | 0.5 | ≥16 | ≥320 | strAa,strBa,aacA4, aac(6')Ib-cra | QnrS1 | dfrA14a | sul2 | ||
32 | 8 | ≥4 | ≥16 | ≥320 | aac(3)-IIda,aadA16a, aac(6')Ib-cr | QnrB52 | dfrA27 | sul1 | tet(A)a | |
K. variicola | ||||||||||
34 | ≤1 | ≤0.25 | ≤0.5 | ≤20 | oqxAa,oqxBa | |||||
E. cloacae | ||||||||||
31 | 8 | 0.5 | ≥16 | ≥320 | aac(3)-IIaa, aadA1a,strA,strB, aac(6')Ib-cr | QnrB1a | dfrA14a | sul2 | tet(A)a |
aGenes called with a less than 100% identity and or length less than 100%. Minimum identity and length for call: 90.00% and 60% respectively.
†aac(6')Ib-cr confers resistance to aminoglycosides and quinolones.
Shading within table indicates susceptibility interpretation according to EUCAST breakpoint table version 7.1, dark grey: resistant, light grey: intermediate and white: susceptible. ID isolate identification number, TOB tobramycin, CIP ciproflacin, TMP trimethoprim, SXT trimethoprim-sulfamethoxazole, SUL sulphonamide, TET tetracyclin, MAC macrolide.